COLUSSI, Gian Luca
 Distribuzione geografica
Continente #
NA - Nord America 4.582
AS - Asia 3.183
EU - Europa 1.783
SA - Sud America 739
Continente sconosciuto - Info sul continente non disponibili 286
AF - Africa 99
OC - Oceania 8
Totale 10.680
Nazione #
US - Stati Uniti d'America 4.375
SG - Singapore 1.171
IT - Italia 926
CN - Cina 532
BR - Brasile 520
VN - Vietnam 404
HK - Hong Kong 285
BD - Bangladesh 271
DE - Germania 160
CA - Canada 99
FR - Francia 98
FI - Finlandia 92
JP - Giappone 84
IN - India 82
GB - Regno Unito 81
AR - Argentina 74
RU - Federazione Russa 71
ID - Indonesia 69
PL - Polonia 61
TR - Turchia 59
NL - Olanda 58
MX - Messico 52
UA - Ucraina 46
SE - Svezia 41
ES - Italia 34
AT - Austria 33
ZA - Sudafrica 27
CO - Colombia 26
EC - Ecuador 26
MY - Malesia 25
IQ - Iraq 24
PE - Perù 24
SA - Arabia Saudita 23
PK - Pakistan 21
VE - Venezuela 20
CL - Cile 19
PH - Filippine 16
MA - Marocco 15
CH - Svizzera 14
PY - Paraguay 13
AE - Emirati Arabi Uniti 12
IR - Iran 12
UZ - Uzbekistan 12
EG - Egitto 11
KE - Kenya 11
KR - Corea 11
IE - Irlanda 10
BO - Bolivia 9
TN - Tunisia 9
BE - Belgio 8
HN - Honduras 8
JM - Giamaica 8
RS - Serbia 8
TT - Trinidad e Tobago 8
TW - Taiwan 8
CR - Costa Rica 7
JO - Giordania 7
LT - Lituania 7
UY - Uruguay 7
AU - Australia 6
AZ - Azerbaigian 6
GT - Guatemala 6
SN - Senegal 6
SV - El Salvador 6
TH - Thailandia 6
BH - Bahrain 5
IL - Israele 5
OM - Oman 5
DZ - Algeria 4
HU - Ungheria 4
KZ - Kazakistan 4
PT - Portogallo 4
RO - Romania 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
GE - Georgia 3
KW - Kuwait 3
NP - Nepal 3
CY - Cipro 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EU - Europa 2
GH - Ghana 2
HR - Croazia 2
KG - Kirghizistan 2
LB - Libano 2
MM - Myanmar 2
NO - Norvegia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
AW - Aruba 1
BB - Barbados 1
BT - Bhutan 1
CV - Capo Verde 1
Totale 10.369
Città #
Singapore 659
Ashburn 554
San Jose 494
Fairfield 314
Council Bluffs 288
Santa Clara 282
Hong Kong 268
Beijing 193
Houston 162
Dallas 151
Ho Chi Minh City 135
Woodbridge 133
Cambridge 118
Seattle 112
Los Angeles 109
New York 105
Milan 91
Wilmington 89
Hanoi 87
Tokyo 78
Helsinki 74
Ann Arbor 46
Chicago 46
Ferrara 46
Rome 46
Lauterbourg 44
São Paulo 41
Princeton 40
Gdansk 38
Redwood City 38
Chandler 37
Jakarta 36
Nuremberg 35
Buffalo 33
Orem 30
Toronto 28
Munich 27
Hefei 26
Izmir 26
Brooklyn 25
Phoenix 25
Jacksonville 24
Mexico City 24
Naples 24
Frankfurt am Main 23
Da Nang 21
San Diego 21
Chennai 20
Lima 20
Haiphong 19
Johannesburg 19
London 19
Memphis 19
Addison 18
Bologna 18
Atlanta 17
Nanjing 17
Warsaw 17
Belo Horizonte 16
Moscow 16
Rio de Janeiro 16
Stockholm 16
Denver 15
Florence 15
Ribeirão Prêto 15
Washington 15
Boston 14
Dearborn 14
Turin 14
Boardman 13
Figino 13
Kuala Lumpur 13
Montreal 13
San Francisco 13
Tampa 13
Vienna 13
Casalgrande 12
Trieste 12
Bari 11
Lappeenranta 11
Manchester 11
Mountain View 11
Baghdad 10
Jeddah 10
New Delhi 10
Quito 10
Salt Lake City 10
Salvador 10
Santiago 10
Brasília 9
Charlotte 9
Genoa 9
Hải Dương 9
Nairobi 9
Newark 9
Palermo 9
Shanghai 9
Tianjin 9
Assago 8
Campinas 8
Totale 6.041
Nome #
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 239
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 237
Pattern of in-hospital changes in drug use in the older people from 2010 to 2016 237
Beta-Blocker Use in Older Hospitalized Patients Affected by Heart Failure and Chronic Obstructive Pulmonary Disease: An Italian Survey From the REPOSI Register 236
Antibiotic use and associated factors in a large sample of hospitalised older people 231
Pain and Frailty in Hospitalized Older Adults 231
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 220
Use and prescription appropriateness of drugs for peptic ulcer and gastrooesophageal reflux disease in hospitalized older people 211
Comparison between drug therapy-based comorbidity indices and the Charlson Comorbidity Index for the detection of severe multimorbidity in older subjects 209
Inappropriate prescription of benzodiazepines in acutely hospitalized older patients 207
Renal Function, Cardiovascular Diseases, Appropriateness of Drug Prescription and Outcomes in Hospitalized Older Patients 191
Implementation of the frailty index in hospitalized older patients: results from the REPOSI register 190
Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register 189
Carotid plaque detection improves the predictive value of CHA2DS2-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study 184
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 183
Impact of Diabetes Mellitus and Its Comorbidities on Elderly Patients Hospitalized in Internal Medicine Wards: Data from the RePoSi Registry 183
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 179
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 177
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 170
Use of Lipid-Lowering Drugs and Associated Outcomes According to Health State Profiles in Hospitalized Older Patients 169
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 168
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 159
Atrial fibrillation management in older hospitalized patients: Evidence of a poor oral anticoagulants prescriptive attitude from the Italian REPOSI registry 154
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 154
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 149
Initiation of Psycholeptic Medication During Hospitalization With Recommendation for Discontinuation After Discharge 147
Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia 146
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 146
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 143
What changed in the Italian internal medicine and geriatric wards during the lockdown 143
Effects of antithrombotic agents on ophthalmological outcomes, cardiovascular risk, and mortality in hypertensive patients with retinal vein occlusion: An exploratory retrospective study 137
Plasma lipoprotein(A) levels as determinants of arterial stiffening in hypertension 127
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 127
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards 126
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 126
Relation between drug therapy-based comorbidity indices, Charlson's comorbidity index, polypharmacy and mortality in three samples of older adults 126
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: analysis of the REPOSI registry 123
Diagnostic role of CD64 expression on neutrophils as biomarker for blood stream infection in liver cirrhosis: some preliminary findings 120
COVID-19 Accelerated Cognitive Decline in Elderly Patients with Pre-Existing Dementia Followed up in an Outpatient Memory Care Facility 118
Elevated Intrarenal Resistive Index Predicted Faster Renal Function Decline and Long-Term Mortality in Non-Proteinuric Chronic Kidney Disease 113
Polyphenols rich diets and risk of type 2 diabetes 104
Bosentan Does Not Affect Renal Resistive Index in Scleroderma/Systemic Sclerosis Patients 102
Effect of Combined Proteinuria and Increased Renal Resistive Index on Chronic Kidney Disease Progression: A Retrospective Longitudinal Study 101
‘Help yourself, so the (circadian) rhythms help you’: Chronobiological insights to promote physical and mental health 100
Effect of heparin treatment on pulmonary embolism and in-hospital death in unvaccinated COVID-19 patients without overt deep vein thrombosis 100
Kidney Disease Management in the Hospital Setting: A Focus on Inappropriate Drug Prescriptions in Older Patients 96
Development and Validation of the Acute PNeumonia Early Assessment Score for Safely Discharging Low-Risk SARS-CoV-2-Infected Patients from the Emergency Department 93
Dulaglutide reduces binge episodes in type 2 diabetic patients with binge eating disorder: A pilot study 91
Effects of insomnia and restless legs syndrome on sleep arterial blood pressure: A systematic review and meta-analysis 86
Aortic stiffness and indexes of disease severity in subjects with previous COVID-19 penumonia:a follow-up study 83
Association of Post-Saline Load Plasma Aldosterone Levels with Left Ventricular Hypertrophy in Primary Hypertension 83
Secondary hyperparathyroidism is associated with postpartum blood pressure in preeclamptic women and normal pregnancies 81
Relationships between NAFLD biochemical scores and left ventricular geometric pattern in naive essential hypertensive patients 81
Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension 81
Prognostic role of malnutrition diagnosed by bioelectrical impedance vector analysis in older adults hospitalized with covid-19 pneumonia: A prospective study 79
Interactions between vitamin D levels, cardiovascular risk factors, and atherothrombosis markers in patients with symptomatic peripheral artery disease 78
Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension 77
Atrial fibrillation and its complications in arterial hypertension: The potential preventive role of ω-3 polyunsaturated fatty acids 76
Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients 74
Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment 74
Role of MR-proADM and Monocyte CD169 in Predicting In-Hospital and 60-Day Mortality in COVID-19 Patients 73
Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study 71
Aldosterone and Left Ventricular Remodeling 70
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis 70
Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge 70
Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies 67
Echocardiographic Comparison of COVID-19 Patients with or without Prior Biochemical Evidence of Cardiac Injury after Recovery 66
Involvement of endothelium-dependent and -independent mechanisms in midazolam-induced vasodilation 65
Benzodiazepines: an old class of new antihypertensive drugs? 63
Effect of intermediate/high versus low dose heparin on the thromboembolic and hemorrhagic risk of unvaccinated COVID-19 patients in the emergency department 62
Intrarenal Vascular Resistance is Associated with a Prothrombotic State in Hypertensive Patients 60
Prognostic scores and early management of septic patients in the emergency department of a secondary hospital: results of a retrospective study 58
Hypertension and type 2 diabetes: lights and shadows about causality 58
Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study 53
Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? 51
Fish Meal Supplementation and Ambulatory Blood Pressure in Patients With Hypertension: Relevance of Baseline Membrane Fatty Acid Composition 51
Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3Kγ 51
Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients 50
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients 49
Has the time come to change the treatment criteria for patients with chronic kidney disease? The “hypofiltering nephron” hypothesis 49
Dietary Salt Intake Is a Determinant of Cardiac Changes After Treatment of Primary Aldosteronism: A Prospective Study 47
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension 43
Effects of the consumption of fish meals on the carotid IntimaMedia thickness in patients with hypertension: a prospective study 42
Glucocorticoid-induced leucine zipper protein regulates sodium and potassium balance in the distal nephron 42
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state 37
Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes 36
Functioning or Non-Functioning Adrenal Adenoma? Probably, Just a Matter of Time 36
Novel role for SGK3 in glucose homeostasis revealed in SGK3/Akt2 double-null mice 34
HICCups and inappropriate ADH secretion syndrome as presentations of tick-borne disease 34
Impact of statin therapy on plasma levels of plasminogen activator inhibitor-1: A systematic review and meta-analysis of randomised controlled trials 34
The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients 31
The Metabolic Syndrome and the Membrane Content of Polyunsaturated Fatty Acids in Hypertensive Patients 31
Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension 31
Omega-3 polyunsaturated fatty acids decrease plasma lipoprotein(a) levels in hypertensive subjects 31
Microalbuminuria and plasma aldosterone levels in nondiabetic treatment-naive patients with hypertension 30
Plasma lipoprotein(a) levels and atherosclerotic renal artery stenosis in hypertensive patients 29
Are Marital Status and Quality Risk Factors for Cardiovascular Diseases? 29
Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients 28
Elevated Blood Pressure in Children of Cardiovascular Risk Mothers: Could Maternal Folic Acid Be the Link? 27
ω-3 Polyunsaturated Fatty Acids Effects on the Cardiometabolic Syndrome and their Role in Cardiovascular Disease Prevention: An Update from the Recent Literature 24
Totale 10.448
Categoria #
all - tutte 50.305
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.305


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022391 0 0 30 35 66 41 15 46 24 18 21 95
2022/2023185 39 17 6 17 17 14 28 11 19 4 8 5
2023/2024294 8 7 23 19 16 53 10 8 4 13 55 78
2024/20251.585 30 11 66 12 238 168 126 86 144 270 252 182
2025/20265.586 368 254 566 554 652 366 490 379 513 635 486 323
2026/2027917 278 433 206 0 0 0 0 0 0 0 0 0
Totale 10.680